Table 5.
Characterisitics | Stable disease group (n = 23) |
Progress disease group (n = 7) |
P |
---|---|---|---|
Age | 59.4 ± 11.8 | 62.9 ± 10.7 | 0.487 |
Gender, n (%) | 0.345 | ||
Male | 5 (21.7%) | 3 (42.9%) | |
Female | 18 (78.3%) | 4 (57.1%) | |
Tumor location, n (%) | |||
Cardia | 4 (17.4%) | 0 | 0.548 |
Fundus | 16 (69.6%) | 4 (57.1%) | 0.657 |
Body | 3 (13.0%) | 3 (42.9%) | 0.120 |
Antrum | 0 | 0 | 1.000 |
Initial diameter (mm) | 7.70 ± 2.79 | 11.86 ± 4.78 | 0.007 |
Initial EUS, n (%) | 1.000 | ||
Low risk | 22 (95.7%) | 7 (100%) | |
High risk | 1 (4.3%) | 0 | |
F/u EUS, n (%) | 0.031 | ||
Low risk | 22 (95.7%) | 4 (57.1%) | |
High risk | 1 (4.3%) | 3 (42.9%) | |
Growth rate per year (%) | −0.5 ± 3.1 | 19.1 ± 9.1 | 0.001 |